Results 21 to 30 of about 1,525,008 (304)

Efficacy of Psychiatric Treatment to Treat a Specific Phobia of Intravitreal Injections in a Patient with Neovascular Age-Related Macular Degeneration

Case Reports in Ophthalmology, 2021
Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) is essential for the treatment of macular diseases such as wet age-related macular degeneration and macular edema.
Atsuta Ozaki, Hisashi Matsubara, Masahiko Sugimoto, Manami Kuze, Mineo Kondo, Takashi Shiroyama   +5 more
doaj   +1 more source

The Association of Intravitreal Anti-VEGF Injections With Kidney Function in Diabetic Retinopathy

Ophthalmology Science, 2023
Purpose: To examine whether patients with diabetic retinopathy receiving intravitreal anti-VEGF injections are at increased risk of kidney function decline. Design: Retrospective cohort study. Participants: Included 187 patients who received intravitreal
Casey C. Bunge, MD, Prarthana J. Dalal, MD, PhD, Elizabeth Gray, MS, Kasen Culler, MD, Julia J. Brown, MD, Susan E. Quaggin, MD, Anand Srivastava, MD, MPH, Manjot K. Gill, MD   +7 more
doaj   +1 more source

Intravitreal injections: past trends and future projections within a UK tertiary hospital

Eye, 2021
To describe past trends and future projections for the number of intravitreal injections being administered at a large tertiary hospital in London, United Kingdom.
Reena Chopra, G. Preston, T. Keenan, Pádraig J. Mulholland, P. Patel, K. Balaskas, R. Hamilton, P. Keane   +7 more
semanticscholar   +1 more source

Acute systemic complications of intravitreal bevacizumab and triamcinolone injections – a comparative study [PDF]

Folia Medica, 2022
Introduction: Macular edema is a common visual threatening complication in patients with diabetic retinopathy and retinal vein occlusion. The injection of intravitreal drugs, such as anti-vascular endothelial growth factor (anti-VEGF) and corticosteroids,
Mohammad Karim Johari, Malihe Askari, Abdulrahim Amini, Masoud Yasemi   +3 more
doaj   +3 more sources

Patient Preference and Treatment Satisfaction With a Port Delivery System for Ranibizumab vs Intravitreal Injections in Patients With Neovascular Age-Related Macular Degeneration

JAMA ophthalmology, 2022
Key Points Question Do patients with neovascular age-related macular degeneration (nAMD) treated with a surgically implanted port delivery system (PDS) with ranibizumab prefer the PDS over intravitreal injections of anti–vascular endothelial growth ...
Margaret Chang, A. Kapre, D. Kaufman, D. Kardatzke, M. Rabena, Shienal Patel, Ashwini Bobbala, Shamika Gune, A. Fung, G. Wallenstein   +9 more
semanticscholar   +1 more source

Questionnaire to Assess Life Impact of Treatment by Intravitreal Injections (QUALITII): Development of a patient-reported measure to assess treatment burden of repeat intravitreal injections

BMJ Open Ophthalmology, 2021
Objective To understand patient burden of treatment of repeated intravitreal injections (IVI) in the management of exudative retinal diseases. Methods and analysis Participants were sampled from a large urban retina specialty practice in Houston, Texas ...
C. McClard, Rui Wang, Victoria A Windham, José Muñoz, Samuel Gomez, S. Fried, Namrata Saroj, C. Regillo, C. Wykoff, A. Strutt   +9 more
semanticscholar   +1 more source

Inflammatory Complications of Intravitreal Anti-VEGF Injections

Journal of Clinical Medicine, 2021
Intravitreal injection of anti-vascular endothelial growth factor (anti-VEGF) agents is a commonly used therapy for numerous retinal diseases. The most commonly used of these medications are bevacizumab, ranibizumab, aflibercept, and brolucizumab ...
J. T. Cox, D. Eliott, L. Sobrin
semanticscholar   +1 more source

Peripheral retinal non-perfusion and treatment response in branch retinal vein occlusion [PDF]

International Journal of Ophthalmology, 2016
AIM: To evaluate the association between the size of peripheral retinal non-perfusion and the number of intravitreal ranibizumab injections in patients with treatment-naive branch retinal vein occlusion (BRVO) and macular edema.
Kaveh Abri Aghdam, Lukas Reznicek, Mostafa Soltan Sanjari, Carsten Framme, Anna Bajor, Annemarie Klingenstein, Marcus Kernt, Florian Seidensticker   +7 more
doaj   +1 more source

Self-sealing hyaluronic acid-coated 30-gauge intravitreal injection needles for preventing vitreous and drug reflux through needle passage

Scientific Reports, 2021
Self-sealing hyaluronic acid (HA)-coated self-sealing 30-gauge needles exhibiting instant leakage prevention of intravitreal humor and injected drug were developed in this study. Ninety New Zealand rabbits were used in this study.
Youngsub Eom, Soomi Kim, Jungah Huh, Mi Young Koh, Jin Young Hwang, Boram Kang, Xiangzhe Li, Moon Sue Lee, Haeshin Lee, Hyo Myung Kim, Jong Suk Song   +10 more
doaj   +1 more source

Intravitreal Aflibercept as a Rescue Therapy for Retinal Neovascularization and Macular Edema due to Eales Disease

Case Reports in Ophthalmological Medicine, 2021
We report the rescue effect of intravitreal aflibercept injections on retinal neovascularization and macular edema due to Eales disease. Case 1 was a 36-year-old female. Intravitreal aflibercept was administered as rescue therapy after persistent retinal
Ning-Yi Hsia, Chun-Ju Lin, Chun-Ting Lai, Henry Bair, Cheng-Hsien Chang, Jane-Ming Lin, Yi-Yu Tsai   +6 more
doaj   +1 more source